title: Gold or penicillamine?
abstract: The recent approval of penicillamine (Cupramine) for use in rheumatoid arthritis has given the physician another remission-inducing drug for this disease. A thorough understanding of penicillamine's administration and toxicity is necessary before the physician begins to use it. Although its efficacy is similar to gold, side effects are considerably more diverse, and longterm side effects require further assessment. This article reviews the clinical use of gold and penicillamine and the factors which may influence the choice of one drug over the other in a given patient.
authors.forename: R C
authors.initials: RC
authors.lastname: Offer
references.citation: N Engl J Med. 1973 May 10;288(19):1007-8
references.pmid: 4633144
references.citation: Br Med J. 1978 Nov 11;2(6148):1326-8
references.pmid: 719380
references.citation: Ann Intern Med. 1980 Jan;92(1):24-9
references.pmid: 7350870
references.citation: Arthritis Rheum. 1978 Jun;21(5):513-5
references.pmid: 96841
references.citation: Proc R Soc Med. 1977;70 Suppl 3:75-7
references.pmid: 122679
references.citation: Arthritis Rheum. 1965 Dec;8(6):1064-79
references.pmid: 5884817
references.citation: Lancet. 1977 Apr 16;1(8016):831-4
references.pmid: 67338
references.citation: Br Med J. 1976 Oct 23;2(6042):979
references.pmid: 1086121
references.citation: Arthritis Rheum. 1977 Sep-Oct;20(7):1413-8
references.pmid: 911360